Pharmacy Policy Shifts – Winning Strategies for Healthcare
Pharmacy benefits took the spotlight in a very active legislative session with a host of bills tackling drug pricing, federal discount programs, cost trends, compliance, and more. The implications could be broad and deep for hospitals and health systems, and inconsistent from state to state.
RxBenefits’ regulatory expert, Wes Hill, and strategic healthcare advisor Sarah Hearn, share insights and interpretations for healthcare leaders in our latest ASHHRA podcast.
This podcast will cover:
- Legislative changes – 1,500 state-level bills aim to increase transparency.
- ERISA complications – Systems that operate in multiple states could experience compliance challenges.
- Savings opportunities – New mandates could create opportunities to optimize spending.
- Drug-level optimization – Find alternatives to high-cost medications.
- Leveraging internal resources – Tap into the distinct skills and strengths of the in-house pharmacy and HR teams.
- Ongoing lawsuits – Several state-level suits on ERISA and PBM permits could influence plan design going forward.
Listen to the full ASHHRA podcast for more in-depth insights, and how RxBenefits can help optimize your plans.
We’re happy to connect with you or your benefits advisor to discuss how your organization can stay prepared in this ever-changing landscape.
You Might Also Enjoy

The Battle Over 340B Drug Pricing (Part 2)
The Battle Over 340B Drug Pricing (Part 2) Explore the complexities and upcoming changes to 340B with RxBenefits and the…

Why HR Leaders Should Care About 340B
Why HR Leaders Should Care About 340B As the second-largest federal drug program in the U.S., the 340B program plays…